Can a new migraine drug stop the dizzy spells?
NCT ID NCT07751497
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This trial tests whether rimegepant, a newer migraine medication, works as well as flunarizine, an older preventive, for reducing days with moderate-to-severe dizziness in people with vestibular migraine. About 400 adults aged 18 to 75 will take one of the two drugs daily for 12 weeks and track their symptoms in a diary. The goal is to see if rimegepant can match flunarizine in cutting down the number of dizzy days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Rimegepant (a CGRP-blocking drug) compared with flunarizine (a calcium-channel blocker)
- What this could lead to
- If rimegepant proves as good as flunarizine, it could offer a newer, potentially better-tolerated option to prevent dizzy spells in people with vestibular migraine.
- What could go wrong
- This is a phase 2 trial, so results are preliminary. Rimegepant might not match flunarizine's effectiveness, and side effects could differ. The open-label design (participants know their treatment) may also bias results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VESTIBULAR MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, No.88 Jiefang Road
Hangzhou, Zhejiang, 310000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wearable eye-tracker aims to catch dizziness in the act
- Ringing relief? migraine drugs tested for tinnitus in new study
- New wearable device aims to diagnose dizziness causes automatically
- New tool could help teens with dizzying migraines get better care
- Scientists hunt for genetic clues to Menière's disease
- VR goggles may ease dizziness for migraine sufferers